Longitudinal retrospective Cholangiocarcinoma chart review study.

Datos básicos

Protocolo:: DIM-95031-001-INT
EUDRACT:
NCT:
Centro:: HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:: 2023
Año de finalización:: 2024

ESTUDIO OBSERVACIONAL

Documentos

No hay documentos

Participantes

Roberto Pedro Díaz Beveridge

Investigador Principal
Maite Giralt Ferrer

Data Manager / Study Coordinator

Grupos

Investigación Clínica y Traslacional en Cáncer

Leader

José Gómez Codina

Financiadores - Promotores

SERVIER AFFAIRES MEDICALES

Resultados del Ensayo Clínico

Publicaciones en Revistas 8

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.

Ortiz A; (...); Rodriguez M

Article. 10.1159/000528784. 2023

Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.

Ochenduszko, Sebastian; (...); Maiques, Inmaculada Maestu

Article. 10.1111/pcmr.13093. 2023

Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE)

Soria, A.; (...); Cerezuela-Fuentes, P.

Meeting Abstract. 10.1016/j.annonc.2023.09.2248. 2023

First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Gonzalez, J. A.; (...); Lopez Pousa, A.

Meeting Abstract. 10.1016/j.annonc.2023.09.1161. 2023

ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma

Martin Broto, Javier; (...); Hindi, Nadia

Meeting Abstract. 2023

Multicenter real-world data of treatment with NALIRI plus 5FU/LV in advanced Spanish pancreatic cancer

Alvarez Gallego, R.; (...); Cubillo, A.

Meeting Abstract. 10.1016/j.annonc.2023.04.238. 2023

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Gronchi, Alessandro; (...); Casali, Paolo Giovanni

Article. 10.1200/JCO.23.00908. 2024

RT after Encorafenib and Binimetinib on BRAF mutated melanoma brain metastases. GEM1802-Phase II

Alvarez, A.; (...); Marquez Rodas, I.